{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:11:46Z","timestamp":1778544706656,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["403.615\/2023-2"],"award-info":[{"award-number":["403.615\/2023-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell&apos;Istruzione dell&apos;Universita e della Ricerca","doi-asserted-by":"publisher","award":["20224PR8HE"],"award-info":[{"award-number":["20224PR8HE"]}],"id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.biopha.2024.117191","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T22:59:55Z","timestamp":1722293995000},"page":"117191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Pharmacological inhibition of CK2 by silmitasertib mitigates sepsis-induced circulatory collapse, thus improving septic outcomes in mice"],"prefix":"10.1016","volume":"178","author":[{"given":"Gustavo","family":"Ferreira Alves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6336-1442","authenticated-orcid":false,"given":"Eleonora","family":"Aimaretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Lu\u00edsa","family":"da Silveira Hahmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Einaudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Porchietto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8588-851X","authenticated-orcid":false,"given":"Chiara","family":"Rubeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6778-3535","authenticated-orcid":false,"given":"Enrica","family":"Marzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Aragno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Eduardo","family":"da Silva-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Cifani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8935-4176","authenticated-orcid":false,"given":"Daniel","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8782-3496","authenticated-orcid":false,"given":"Massimo","family":"Collino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.117191_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2024.117191_bib2","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201810128","article-title":"Sepsis therapies: learning from 30 years of failure of translational research to propose new leads","volume":"12","author":"Cavaillon","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.biopha.2024.117191_bib3","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.biopha.2024.117191_bib4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13054-018-2102-1","article-title":"Definitions and pathophysiology of vasoplegic shock","volume":"22","author":"Lambden","year":"2018","journal-title":"Crit. Care"},{"key":"10.1016\/j.biopha.2024.117191_bib5","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2024.117191_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.837180","article-title":"Pharmacological Inhibition of FAK-Pyk2 Pathway Protects Against Organ Damage and Prolongs the Survival of Septic Mice","volume":"13","author":"Alves","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.117191_bib7","article-title":"X-Linked Immunodeficient Mice With No Functional Bruton\u2019s Tyrosine Kinase Are Protected From Sepsis-Induced Multiple Organ Failure","volume":"11","author":"O\u2019Riordan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.117191_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1223014","article-title":"Baricitinib protects mice from sepsis-induced cardiac dysfunction and multiple-organ failure","volume":"14","author":"Verra","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.117191_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00070","article-title":"The casein kinase 2 inhibitor, CX-4945, as an anti-cancer drug in treatment of human hematological malignancies","volume":"6","author":"Chon","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2024.117191_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41392-021-00567-7","article-title":"Protein kinase CK2: a potential therapeutic target for diverse human diseases","volume":"6","author":"Borgo","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2024.117191_bib11","doi-asserted-by":"crossref","first-page":"6484","DOI":"10.1158\/1078-0432.CCR-13-0265","article-title":"Targeting Protein Kinase CK2 Suppresses Prosurvival Signaling Pathways and Growth of Glioblastoma","volume":"19","author":"Zheng","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2024.117191_bib12","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ijc.29043","article-title":"CK2\u03b1 phosphorylates DBC1 and is involved in the progression of gastric carcinoma and predicts poor survival of gastric carcinoma patients","volume":"136","author":"Bae","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2024.117191_bib13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1182\/blood-2010-01-266320","article-title":"A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway","volume":"118","author":"Zheng","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2024.117191_bib14","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1158\/1541-7786.MCR-16-0291","article-title":"Constitutive Phosphorylation of STAT3 by the CK2\u2013BLNK\u2013CD5 Complex","volume":"15","author":"Rozovski","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.biopha.2024.117191_bib15","doi-asserted-by":"crossref","first-page":"7637","DOI":"10.1073\/pnas.92.17.7637","article-title":"Constitutive phosphorylation of I kappa B alpha by casein kinase II","volume":"92","author":"Barroga","year":"1995","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2024.117191_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110163","article-title":"CX-4945 inhibits fibroblast-like synoviocytes functions through the CK2-p53 axis to reduce rheumatoid arthritis disease severity","volume":"119","author":"Luo","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2024.117191_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/srep14816","article-title":"The protein kinase 2 inhibitor tetrabromobenzotriazole protects against renal ischemia reperfusion injury","volume":"5","author":"Ka","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.117191_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11010-011-0956-5","article-title":"Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer","volume":"356","author":"Pierre","year":"2011","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.biopha.2024.117191_bib19","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.biopha.2024.117191_bib20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/SHK.0000000000001212","article-title":"Minimum Quality Threshold in Pre-Clinical Sepsis Studies (MQTiPSS): An International Expert Consensus Initiative for Improvement of Animal Modeling in Sepsis","volume":"50","author":"Osuchowski","year":"2018","journal-title":"Shock"},{"key":"10.1016\/j.biopha.2024.117191_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-4804(80)90037-2","article-title":"Sepsis and septic shock\u2014A review of laboratory models and a proposal","volume":"29","author":"Wichterman","year":"1980","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.biopha.2024.117191_bib22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12885-020-6650-9","article-title":"Influence of Casein kinase II inhibitor CX-4945 on BCL6-mediated apoptotic signaling in B-ALL in vitro and in vivo","volume":"20","author":"Richter","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2024.117191_bib23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2\u2212\u0394\u0394CT Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.biopha.2024.117191_bib24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1172\/JCI114422","article-title":"Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages","volume":"85","author":"Granger","year":"1990","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2024.117191_bib25","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.21037\/apm-20-1855","article-title":"Biomarkers for the diagnosis of sepsis-associated acute kidney injury: systematic review and meta-analysis","volume":"10","author":"Xie","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.biopha.2024.117191_bib26","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201810128","article-title":"Sepsis therapies: learning from 30 years of failure of translational research to propose new leads","volume":"12","author":"Cavaillon","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.biopha.2024.117191_bib27","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ajpath.2023.01.016","article-title":"Protein Kinase CK2 Promotes Proliferation, Abnormal Differentiation, and Proinflammatory Cytokine Production of Keratinocytes via Regulation of STAT3 and Akt Pathways in Psoriasis","volume":"193","author":"Huang","year":"2023","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2024.117191_bib28","doi-asserted-by":"crossref","first-page":"7736","DOI":"10.1073\/pnas.0409818102","article-title":"Inhibition of protein kinase CK2 prevents the progression of glomerulonephritis","volume":"102","author":"Yamada","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2024.117191_bib29","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.3390\/ijms25115819","article-title":"Elevated Serum KIM-1 in Sepsis Correlates with Kidney Dysfunction and the Severity of Multi-Organ Critical Illness","volume":"25","author":"Brozat","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.117191_bib30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41581-023-00683-3","article-title":"Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup","volume":"19","author":"Zarbock","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.biopha.2024.117191_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/09680519990050011801","article-title":"Activation of protein kinase CK2 by LPS is mediated by the MAP kinase pathway","volume":"5","author":"Means","year":"1999","journal-title":"J. Endotoxin Res."},{"key":"10.1016\/j.biopha.2024.117191_bib32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/mi.2012.57","article-title":"Protein kinase CK2 is a critical regulator of epithelial homeostasis in chronic intestinal inflammation","volume":"6","author":"Koch","year":"2013","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.biopha.2024.117191_bib33","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1007\/s00018-009-9153-z","article-title":"Protein Kinase CK2 in Health and Disease","volume":"66","author":"Dominguez","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2024.117191_bib34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1681\/ASN.2015060670","article-title":"I\u03baB Kinase Inhibitor Attenuates Sepsis-Induced Cardiac Dysfunction in CKD","volume":"28","author":"Chen","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2024.117191_bib35","doi-asserted-by":"crossref","first-page":"23953","DOI":"10.1074\/jbc.M313731200","article-title":"Casein Kinase II-mediated Phosphorylation of NF-\u03baB p65 Subunit Enhances Inducible Nitric-oxide Synthase Gene Transcription in Vivo","volume":"279","author":"Chant\u00f4me","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.117191_bib36","doi-asserted-by":"crossref","first-page":"11375","DOI":"10.1158\/0008-5472.CAN-05-1602","article-title":"Inducible I\u03baB Kinase\/I\u03baB Kinase \u03b5 Expression Is Induced by CK2 and promotes aberrant nuclear factor-\u03baB activation in breast cancer cells","volume":"65","author":"Eddy","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2024.117191_bib37","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1172\/JCI95720","article-title":"sNASP inhibits TLR signaling to regulate immune response in sepsis","volume":"128","author":"Yang","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2024.117191_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12026-015-8633-5","article-title":"Involvement of ATF3 in the negative regulation of iNOS expression and NO production in activated macrophages","volume":"62","author":"Jung","year":"2015","journal-title":"Immunol. Res."},{"key":"10.1016\/j.biopha.2024.117191_bib39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2147\/JIR.S178084","article-title":"Inflammasomes: Pandora\u2019s box for sepsis","volume":"Volume 11","author":"Kumar","year":"2018","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.biopha.2024.117191_bib40","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/jcsm.12763","article-title":"Inhibition of the NLRP3\/IL-1\u03b2 axis protects against sepsis-induced cardiomyopathy","volume":"12","author":"Busch","year":"2021","journal-title":"J. Cachex-.-. Sarcopenia Muscle"},{"key":"10.1016\/j.biopha.2024.117191_bib41","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pharmthera.2017.02.040","article-title":"Recent advances in the pathophysiology and molecular basis of sepsis-associated organ dysfunction: Novel therapeutic implications and challenges","volume":"177","author":"Hattori","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2024.117191_bib42","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1097\/CCM.0000000000003009","article-title":"Activator Protein-1 Decoy Oligodeoxynucleotide Transfection Is Beneficial in Reducing Organ Injury and Mortality in Septic Mice","volume":"46","author":"Imaizumi","year":"2018","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.biopha.2024.117191_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72136-x","article-title":"Beneficial effect of STAT3 decoy oligodeoxynucleotide transfection on organ injury and mortality in mice with cecal ligation and puncture-induced sepsis","volume":"10","author":"Imbaby","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.117191_bib44","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0014-2999(90)90062-B","article-title":"Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo","volume":"182","author":"Thiemermann","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2024.117191_bib45","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1476-5381.1993.tb12879.x","article-title":"Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock","volume":"108","author":"Szab\u00f3","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2024.117191_bib46","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1378\/chest.106.1.250","article-title":"Inhibition of Nitric Oxide Synthesis Improves the Vasoconstrictive Effect of Noradrenaline in Sepsis","volume":"106","author":"Landin","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.biopha.2024.117191_bib47","doi-asserted-by":"crossref","first-page":"R222","DOI":"10.1186\/cc10462","article-title":"Effects of changes in arterial pressure on organ perfusion during septic shock","volume":"15","author":"Thooft","year":"2011","journal-title":"Crit. Care"},{"key":"10.1016\/j.biopha.2024.117191_bib48","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224010758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224010758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:29:14Z","timestamp":1778542154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224010758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":48,"alternative-id":["S0753332224010758"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117191","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological inhibition of CK2 by silmitasertib mitigates sepsis-induced circulatory collapse, thus improving septic outcomes in mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117191"}}